Japan Approves Worlds First iPS Therapies for Parkinsons, Heart Failure Conditional approval granted for Sumitomo Pharmas ...

In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. When Elon Musk was at Davos last week, an interviewer asked him if he thought aging ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer ...

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor inhibition where conventional immunotherapy fails. (Nanowerk Spotlight) ...

A recent review published in the journal Current Clinical Microbiology Reports discussed how modern lifestyle factors affect the microbiome. Changes in the metabolomic output and composition of the ...

Sure, here is the description with all links and additional text removed: If you found this video enjoyable, kindly show your support by giving it a thumbs up, leaving a comment, and subscribing for ...

Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body. Tumors are packed with macrophages, immune cells that should attack cancer ...

As we age, we don’t recover from injury or illness like we did when we were young. But new research from UCSF has found gene regulators — proteins that turn genes on and off — that could restore the ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer. Rather than targeting cancer cells ...